Cenforce 150 mg is a high-strength formulation of Sildenafil Citrate, a potent PDE5 inhibitor used for the treatment of erectile dysfunction (ED) in adult men. It is typically prescribed for patients who do not respond adequately to lower doses such as 50 mg or 100 mg, offering enhanced therapeutic effect and longer-lasting results.

Packaging Details – Cenforce 150 mg Tablets

• Form: Oral film-coated tablet

• Strength: Sildenafil Citrate 100 mg per tablet

• Pack Size: Box of 100 tablets

• Packaging Type:

  • Typically packed in blister strips (e.g., 10 tablets per strip × 10 strips per box)

Norsunate 100 (Artesunate 100 mg) is an antimalarial medication used for the treatment of malaria caused by Plasmodium falciparum and other malaria parasites. Artesunate belongs to the artemisinin group of medicines and works by producing free radicals that damage the parasite’s proteins, leading to its death. It provides rapid symptom relief and is especially effective in treating mild to moderate malaria cases.

Artesunate acts quickly to reduce parasite count in the bloodstream and is often used in combination with other antimalarial drugs as part of Artemisinin-based Combination Therapy (ACT) to prevent resistance and recurrence. Always use this medicine under the supervision of a qualified healthcare provider.

Rybelsus® 7 mg is an oral GLP-1 receptor agonist containing semaglutide, designed to help adults with type 2 diabetes manage their blood sugar levels effectively. As an intermediate-strength dose, it is commonly used after initial dose titration and provides significant benefits in glycemic control while also supporting weight loss by reducing appetite and slowing digestion. Rybelsus 7 mg offers a convenient, once-daily, non-injectable option for patients seeking improved metabolic health and body weight regulation as part of a comprehensive diabetes care plan.

Packaging Information

• Product Name: Rybelsus®

• Generic Name: Semaglutide Tablets 7 mg

• Strength: 7 mg per tablet

• Quantity: 10 tablets per pack

• Form: Oral tablet (film-coated)

• Tablet Appearance: Oval, light orange, debossed with tablet strength

• Packaging Type:

  • Primary: Blister strip

  • Secondary: Printed carton box containing blister(s) and patient information leaflet (PIL)